US 7402299
Intracorporeal medicaments for photodynamic treatment of disease
granted A61KA61K31/352A61K41/0038
Quick answer
US patent 7402299 (Intracorporeal medicaments for photodynamic treatment of disease) held by Provectus Pharmatech, Inc. expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/352, A61K41/0038, A61K41/0057, A61K41/0071